Navigation Links
Cascades Technologies, Inc. Chosen to Deliver IT Support on a DoD Blast Injury Research Program
Date:11/18/2008

HERNDON, Va., Nov. 18 /PRNewswire-USNewswire/ -- Cascades Technologies, Inc. (CTi), a federal government professional consulting firm, announced that it was chosen to provide a variety of web-based services in support of DoD's Blast Injury Research Program. Working closely with prime contractor Science Applications International Corporation (NYSE: SAI) and the Blast Injury Research Program Coordinating Office (PCO) at the U.S. Army Medical Research and Materiel Command (USAMRMC), CTi will support Phase 3 of the project after having successfully supported the first two phases of the program.

Established in July 2006 by DoD Directive 6025.21E (Medical Research for Prevention, Mitigation, and Treatment of Blast Injuries), the purpose of the program is to coordinate and manage relevant DoD research efforts and programs for the prevention, mitigation, and treatment of blast injuries. Leveraging research and expertise from both within and outside the DoD, the Blast Injury Research Program is focused on filling knowledge gaps in three key topic areas--Injury Prevention, Acute Treatment, and Reset (activities necessary to return injured war fighters to duty readiness or ensuring a healthy return to civilian life).

"The debt we owe our brave war fighters for their sacrifices is immeasurable, therefore, we are deeply honored to do our part to help ensure everything is done to try to minimize the loss of life, improve the quality of life and reduce the long term impact of blast-related traumas faced by our men and women in uniform," said Alfredo Casta, President and CEO of Cascades Technologies, Inc. SAIC senior vice president and business unit general manager Robert McCord added, "Nothing we do is more important than the service we provide to help ensure our military personnel can be successful and safe."

Among some of the Program's early accomplishments include advanced simulation of blast-induced brain injuries to improve the design of personal protective equipment, development of a prototype agent using freeze-dried platelets that improves clotting time and clot strength to facilitate wound-healing, procedures and products that may lengthen amputated fingers and restore function to blast-injured limbs and faces. Dozens of other accomplishments and medical breakthroughs are listed on the Program's new website.

Under Phase 3, CTi will design, develop and maintain databases for collecting, managing and analyzing blast injury research program data from summaries of ongoing clinical research to program budget data and much more. CTi will also manage the content for an informational website to disseminate blast injury research program information to the public, DoD leadership and researchers, to include research publications, upcoming events, and news items. Additionally, CTi will develop and maintain a web-based, password-protected program management system for collecting and sharing information among DoD blast injury researchers.

CTi's innovative Puerto Rico Applications Development And Support center (PRADAS) will develop the bulk of the software working closely with CTi's Headquarters Program Management Office, SAIC, and the staff at the Blast Injury Research PCO. The CTi team will apply CMMI Level 2 best practices in support of this effort.

Cascades Technologies, Inc. (CTi), is a customer-focused professional consulting firm committed to acting as a reliable advisor to its clients; driving efficiency and productivity, resulting in improved services. From diagnosis to solutions, CTi identifies areas of improvement and helps deliver results, including customized technology applications specific to the client's needs. An 8(a) certified, Hispanic-owned business, CTi's primary customers are civilian agencies within the Federal government and various health related entities. In addition to its Herndon, VA headquarters, CTi has established offices in Washington, DC, and San Juan, Puerto Rico.

To learn more about Cascades Technologies, Inc. (CTi), call 703.793.7222 or visit www.cascadestech.com


'/>"/>
SOURCE Cascades Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. GSA Selects Cascades Technologies, Inc. (CTi) to Support USA.gov
2. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
3. Emisphere Technologies, Inc. Appoints Paul Lubetkin as Vice President and General Counsel
4. Microchip Biotechnologies, Inc. Secures Exclusive License to Use New University of Alberta Technology for Developing Microfluidic Devices
5. Emisphere Technologies, Inc. Appoints Michael R. Garone chief financial officer
6. Neurobiological Technologies, Inc. Reports Receipt of Notice From Nasdaq
7. Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2007 Results; Teleconference and Webcast to be held on September 18, 2007
8. Neurobiological Technologies, Inc. Reports Fourth Quarter and Fiscal Year-End Financial Results for 2007 Announces 1-for-7 Reverse Stock Split
9. Neurobiological Technologies, Inc. (Nasdaq: NTIID)
10. Emisphere Technologies, Inc. and Eli Lilly and Company Settle Ongoing Litigation
11. Maven Biotechnologies, LLC to Present at BIOCOM Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... Ann Arbor, MI (PRWEB) , ... February 16, 2017 , ... ... between 5:00-7:00 p.m. The event will be held at Avomeen Analytical Services (4840 ... hosted by a MichBio member organization. They provide an opportunity to interact with peers, ...
(Date:2/16/2017)... CALABASAS, Calif. , Feb. 16, 2017 /PRNewswire/ ... on developing groundbreaking therapies to treat severe neurological ... in children treated with AGT-181, the company,s investigational ... syndrome (also known as mucopolysaccharidosis type I, or ... Phase 2 proof-of-concept (POC) study, presented today at ...
(Date:2/16/2017)... , February 16, 2017 ... the infusion of innovative telemedicine application, new and ... that are experiencing a boom worldwide. The healthcare ... advancement of technologies, services and new therapies for ... RQHTF) (TSX-V: RHT), Cellectar Biosciences, Inc. (NASDAQ: ...
(Date:2/16/2017)... ... February 16, 2017 , ... AxioMed announced ... professor and Harvard trained surgeon, completed the procedure on Monday, Jan. 30 at ... practicing female physician suffering from degenerative disc disease with radiculomyelopathy, as a result ...
Breaking Biology Technology:
(Date:1/18/2017)... , Jan. 18, 2017  In vitro diagnostic (IVD) ... mergers and acquisitions (M&A), and Kalorama Information expects that ... acquisitions have been shifting. Generally, uncertainty in reimbursement and ... the U.S. has changed the acquisitions landscape. Instead of ... in companies buying partners outside of their home country ...
(Date:1/13/2017)... 13, 2017 Sandata Technologies, LLC, a ... homecare industry, including Electronic Visit Verification™ (EVV™), announced ... Jugs, as Senior Vice President of Product Management. ... of homecare experience to Sandata, where he will ... to align Sandata,s suite of solutions with the ...
(Date:1/12/2017)... NEW YORK , Jan. 12, 2017  New research ... around the office of the future.  1,000 participants were simply ... last three months which we may consider standard issue.  Insights ... office of 2017 were also gathered from futurists and industry ... and Dr. James Canton .  Some ...
Breaking Biology News(10 mins):